Dr. Ahmed Kelani to Souq Al Dawaa :
28 April 2025
EIPICO achieves 30% growth in sales during the first quarter of 2025, exceeding 1.8 billion EGP.
In a statement by Dr. Kelani to Souq Al Dawaa, EIPICO's performance, according to IQVIA data for pharmaceutical companies in the local market during the first quarter of this year, showed:
- We achieved 30% sales growth.
- Sales volume exceeds 1.8 billion EGP, with a market share of 2.7%.
- We achieved good growth in exports during the same period.
- A program of visits to many countries to follow up on the development of foreign markets and open new ones.
- A program of visits to many countries to follow up on the development of foreign markets and open new ones.
- We are participating in many international conferences and exhibitions this year.
More details :